Study: New DNA Vaccine Shuts Down Immune Cells that Cause Type 1 Diabetes
July 1, 2013 5:05 PM
comment(s) - last by
It leaves the rest of the immune system alone, though
Type 1 diabetes is a lifelong disease, but researchers at Stanford University are hoping to eliminate the effects of the disease -- and eventually cure it -- with a new vaccine.
Researchers from the Stanford School of Medicine -- led by Lawrence Steinman, MD, professor of pediatrics and of neurology and neurological sciences at Stanford -- have created a DNA vaccine that fights
type 1 diabetes
by targeting only a certain population of cells in the immune system without destroying the whole thing.
The vaccine consists of an altered piece of DNA, which holds the proinsulin gene. Beta cells, which are the only cells that make insulin in the body, start out as proinsulin precursor proteins. The beta cells, like all cells, display small pieces of the proteins they make on their surfaces called peptides, and the proinsulin peptides on the surface of beta cells cause misdirected CD8 cells (which are immune cells that patrol the cell surfaces for foreign peptides) to attack the beta cells.
The new DNA vaccine seeks out CD8 cells
targeting proinsulin; not all CD8 cells. If the vaccine had shut down the normal behavior of all CD8 cells, it would interfere with the patient's immune system and stop their bodies from being able to fight off infections and serious issues like cancer. Hence, shutting the whole system down isn't a better option.
That's why the vaccine only targets proinsulin-attacking CD8 cells and stops them from destroying beta cells while leaving everything else alone.
To test the vaccine, the research team recruited 80 type 1 diabetic patients that
required insulin therapy
. They divided the patients into five different groups, where four received different doses of the vaccine and one received a placebo.
Over the course of 12 weeks, the researchers measured levels of C-peptide in the patients, which is a piece of proinsulin that is cut off when insulin is pulled out of the proinsulin molecule. C-peptide is thought to fight off diabetic complications, such as eye and kidney damage.
The team checked the C-peptide levels before they began, then at five and 15 weeks, and then six, nine, 12, 18 and 24 months after starting on the vaccination. During these checks, blood was drawn 30, 60, 90 and 120 minutes after patients drank a modified milkshake.
According to results, levels of proinsulin-targeting CD8 cells were significantly depleted in patients who received the vaccine, compared with those getting placebo. However, other CD8 cells remained intact and left alone. Patients on the vaccine either had the same C-peptide levels or even increased levels, which would help them fight off diabetic complications later in life.
This article is over a month old, voting and posting comments is disabled
Not a cure....
7/2/2013 11:22:31 AM
I don't believe this is a "cure" in the traditional sense as in curing someone who already has the disease. A type I diabetic have lost all the beta cells which produce insulin as a result of the immune system attacking and killing the cells. I don't think this vaccine will result in the beta cells coming back/regenerating once they have been killed off.
What it can do, based on these initial studies, is block/prevent further deterioration/dead of beta cells in an individual in the early stages of the disease. This effectively will result in someone not becoming a type I diabetic by protecting the beta cells from being attacked by the immune system.
And if used as a general vaccine for the population (like the polio, chicken pox, MMR type vaccines) it could ultimately prevent formation of the disease in the population....thus curing/preventing the disease in the population.
"A lot of people pay zero for the cellphone ... That's what it's worth." -- Apple Chief Operating Officer Timothy Cook
Gene Therapy Controls, Cures Type 1 Diabetes in Dogs
February 11, 2013, 1:59 PM
Artificial Pancreas Improves Glucose Control by 15%, Benefits Type 1 Diabetes Patients
January 30, 2013, 5:55 PM
U.S. Air Force F-35 Lightning II, F-22 Raptor Team Up for “Integration Training”
November 19, 2014, 9:15 AM
U.S. Marshals Using Fake, Airplane-based Cell Towers to Scan Cell Phones of Americans
November 14, 2014, 9:05 AM
Ford Enlists Wind Energy Corp. to Provide Wind, Solar Energy to Four U.S. Dealerships
November 10, 2014, 10:58 AM
Disney Reveals Star Wars Ep. VII Title -- "The Force Awakens"
November 6, 2014, 3:45 PM
U.S. Navy Lockheed F-35C Completes First Carrier Landing
November 4, 2014, 12:44 PM
Microsoft Co-founder Paul Allen Donates $100M to Fight Raging Ebola Epidemic
October 23, 2014, 6:05 PM
Most Popular Articles
Wal-Mart: Miss Thanksgiving, Get Xbox One + Master Chief Collection for $299
November 17, 2014, 9:40 PM
Nokia Lumia 635 LTE Windows Phone is Only $40 at Best Buy on Black Friday
November 18, 2014, 11:59 AM
Sweden Mulls Labelling "Sexist" Video Games in the Wake of Gamergate
November 17, 2014, 2:00 PM
It's Official: Twitter is Profitable "Junk"
November 16, 2014, 10:45 PM
Austrian Pilots Call Surface 3 Pro Flight Bag a "Dream Come True"
November 14, 2014, 2:00 PM
Latest Blog Posts
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
Space Terrorism is a Looming Threat For the United States
Apr 23, 2014, 7:47 PM
More Blog Posts
Copyright 2014 DailyTech LLC. -
Terms, Conditions & Privacy Information